We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

DarioHealth Corp (DRIO) USD0.0001

Sell:$0.68 Buy:$0.81 Change: $0.0024 (0.34%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$0.68
Buy:$0.81
Change: $0.0024 (0.34%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$0.68
Buy:$0.81
Change: $0.0024 (0.34%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Contact details

Address:
322 W 57Th St. #33B
NEW YORK
10019
United States
Telephone:
+1 (646) 6654667
Website:
https://shop.mydario.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DRIO
ISIN:
US23725P2092
Market cap:
$23.86 million
Shares in issue:
34.10 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Erez Raphael
    Chief Executive Officer, Director
  • Zvi Ben-David
    Chief Financial Officer, Treasurer, Secretary
  • Tomer Ben-Kiki
    Chief Operating Officer
  • Steven Nelson
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.